ZA767572B - 4-(3-(substituted amino)-2-hydroxypropoxy)-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols - Google Patents

4-(3-(substituted amino)-2-hydroxypropoxy)-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols

Info

Publication number
ZA767572B
ZA767572B ZA767572A ZA767572A ZA767572B ZA 767572 B ZA767572 B ZA 767572B ZA 767572 A ZA767572 A ZA 767572A ZA 767572 A ZA767572 A ZA 767572A ZA 767572 B ZA767572 B ZA 767572B
Authority
ZA
South Africa
Prior art keywords
naphthalenetriols
hydroxypropoxy
tetrahydro
substituted amino
amino
Prior art date
Application number
ZA767572A
Other languages
English (en)
Inventor
M Condon
R Fox
F Hauck
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA767572B publication Critical patent/ZA767572B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA767572A 1976-02-09 1976-12-21 4-(3-(substituted amino)-2-hydroxypropoxy)-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols ZA767572B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/656,769 US4048231A (en) 1976-02-09 1976-02-09 4-[3-(Substituted amino)-2-hydroxypropoxy]-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols

Publications (1)

Publication Number Publication Date
ZA767572B true ZA767572B (en) 1977-11-30

Family

ID=24634483

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA767572A ZA767572B (en) 1976-02-09 1976-12-21 4-(3-(substituted amino)-2-hydroxypropoxy)-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols

Country Status (18)

Country Link
US (2) US4048231A (de)
JP (1) JPS5943454B2 (de)
AT (1) AT349011B (de)
AU (1) AU509744B2 (de)
BE (1) BE850452A (de)
CA (1) CA1105483A (de)
CH (1) CH618676A5 (de)
DE (1) DE2701626A1 (de)
DK (1) DK51877A (de)
FR (1) FR2361335A1 (de)
GB (2) GB1564160A (de)
HU (1) HU173781B (de)
IE (1) IE45258B1 (de)
NL (1) NL7700421A (de)
NO (1) NO770415L (de)
PL (1) PL108213B1 (de)
SE (1) SE7701390L (de)
ZA (1) ZA767572B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003664B1 (de) * 1978-02-08 1982-02-17 Imperial Chemical Industries Plc Alkanolaminderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
JPS6241829Y2 (de) * 1980-03-28 1987-10-26
FR2507181A1 (fr) 1981-06-05 1982-12-10 Sanofi Sa Nouveaux ethers de phenol actifs sur le systeme cardiovasculaire, leur procede de preparation et leur utilisation dans des medicaments
EP2475640B1 (de) * 2009-09-11 2015-11-04 Ricoh Company Ltd. Abgangssubstituent-haltige verbindung, organisches halbleitermaterial, organische halbleiterfolie mit dem material, organische elektronische vorrichtung mit dem film, verfahren zur herstellung des filmartigen produkts, pi-elektron-konjugierte verbindung und verfahren zur herstellung der pi-konjugierten verbindung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543344A1 (de) * 1966-04-22 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen 1-Amino-3-aryloxypropanol-2-aethern
DE2130393C3 (de) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen

Also Published As

Publication number Publication date
PL108213B1 (pl) 1980-03-31
FR2361335A1 (fr) 1978-03-10
ATA77977A (de) 1978-08-15
BE850452A (fr) 1977-07-18
US4048231A (en) 1977-09-13
AT349011B (de) 1979-03-12
GB1564159A (en) 1980-04-02
DK51877A (da) 1977-08-10
HU173781B (hu) 1979-08-28
NL7700421A (nl) 1977-08-11
CA1105483A (en) 1981-07-21
CH618676A5 (de) 1980-08-15
DE2701626A1 (de) 1977-08-11
GB1564160A (en) 1980-04-02
JPS5297953A (en) 1977-08-17
IE45258B1 (en) 1982-07-28
FR2361335B1 (de) 1980-04-30
IE45258L (en) 1977-08-09
AU2089076A (en) 1978-06-29
NO770415L (no) 1977-08-10
SE7701390L (sv) 1977-08-10
US4093814A (en) 1978-06-06
AU509744B2 (en) 1980-05-22
JPS5943454B2 (ja) 1984-10-22

Similar Documents

Publication Publication Date Title
AU2241677A (en) 4,5-dichloroimidazole-2-carboxylic acid derivatives
GB2041361B (en) 1,2-dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives
EG13910A (en) 1,3,4 substituted parazoline derivatives
GB2067567B (en) 24,24-difluoro-cyclovitamin d3 derivatives
GB1542361A (en) 1,4-benzo-dioxan derivatives
AU508007B2 (en) 1, 5-Disubstituted-2-Pyrrolidones
ZA807494B (en) 2,3-indoledione derivatives
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
AU512404B2 (en) 2, 6-Methano-2H-l-Benzoxocins
AU500386B2 (en) 1,2,6-thidiazinones
ZA767572B (en) 4-(3-(substituted amino)-2-hydroxypropoxy)-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
AU2546577A (en) 5, 5-trimethylhexanoyl-ferrocene
AU505974B2 (en) 3', 4'-dideoxykanamcin b
AU2468877A (en) 1,4 -dicyanobytene
IL52884A0 (en) The preparation of 2,3-cycloalkenopyridines
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives
AU514741B2 (en) 5,6-dehydropenicillins
AU3178777A (en) Substituted 4,5-dihydroxy-imidazolidine-2-thiones
GB1541820A (en) 1,4-oxathianes
GB2042519B (en) 1,1,2-triphenylethane and -ehylene derivatives
ZA777214B (en) Tetrahydro-1,3,5-oxadiazin-4-one derivatives
ZA774088B (en) 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide
GB1554045A (en) 13,14-didehydroprostaglandins
AU515307B2 (en) 1, 3-benzodioxine derivatives